Orpyx to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 12, 2024) - Orpyx, a med tech + touch company dedicated to transforming diabetic limb...
Day: April 12, 2024
Asia Green Biotechnology Corp. Announces Change of Auditor And Discontinuation of Operations in Asia
CALGARY, AB / ACCESSWIRE / April 12, 2024 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA), announced today...
Beauty-Stem Biomedical Celebrates Grand Opening in Arcadia, Los Angeles
Beauty-Stem Biomedical, a cutting-edge stem cell supplement company, marked a momentous occasion with its grand opening in the vibrant city...
Community Fundraiser Hosted by CFC in Support of Infertility Awareness Week
Canadian Fertility Consulting and Fertility Matters Canada Unite for Virtual Paint Night FundraiserTORONTO, ON / ACCESSWIRE / April 12, 2024...
Akanda Announces Plans to Enter Blockchain and AI Technology Sector
London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical...
LIVIN Foundation Teams Up With Healthtek, Inc. and Leading Non-Profits to Launch Revolutionary Suicide Prevention Platform
MINNEAPOLIS, MN / ACCESSWIRE / April 12, 2024 / LIVIN Foundation, a Minnesota-based non-profit and trailblazer in mental health advocacy,...
CND Life Sciences to Highlight Momentum of Skin Biopsy Diagnostic Tool for Parkinson’s Disease and Related Disorders at the American Academy of Neurology 2024 Annual Meeting
- Synuclein-One Study plenary session on Monday, April 15 at 9:15 a.m. MT will report the detection of cutaneous phosphorylated...
Red Light Holland’s Largest Psilocybin Shipment Received by CCrest Labs in Montreal with Health Canada Approved Import Permit
Red Light Holland Advances Psilocybin Research Collaboration with CCrest Labs and PharmAla BiotechLargest Shipment of Psilocybin from the Company's Farm...
Glow Announces Appointment of Rob Carducci as New CEO and Board Changes To Lead Next Stage of Growth
Toronto, Ontario--(Newsfile Corp. - April 12, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or...
Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study
Halifax, Nova Scotia--(Newsfile Corp. - April 12, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")...
Akanda Looks to Commercialize and Capitalize on Germany’s Legalization of Cannabis, Opening Path to $3BN Market
London, United Kingdom--(Newsfile Corp. - April 12, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical...
Sunshine Biopharma Announces Reverse Stock Split
NEW YORK, NY / ACCESSWIRE / April 12, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company" or "Sunshine Biopharma"), a...
Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year
ANNOUNCEMENT NO. 261 Clarification of guidance for revenue and lower than expected operating profit in the 2023/24 financial year According...
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products
Signifies the first major step towards the application process for the certification of its Mango ED oral dissolvable products by...
Teladoc Health to Announce First Quarter 2024 Financial Results
PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,...
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton
Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiariesMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April...
Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
-Adenosine clinical development pausedWESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company...
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference
BOSTON, April 12, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting
Innovative design of ongoing Phase 3 clinical program expected to set precedent for future clinical trials in essential tremorBOSTON, April...
Ultragenyx Announces Upcoming Data Presentations at American Academy of Neurology (AAN) 2024 Annual Meeting
Company will host investor call on April 17 at 8:00 a.m. ET to discuss new data from GTX-102 Phase 1/2...